A Science & Innovation Webinar, sponsored by Impact Education, LLC.

Retinal diseases result in remarkable morbidity among plan members, including vision loss and blindness. Furthermore, disparities exist in incidence and outcomes among those affected by social determinants of health (SDOH). This webcast, presented by ManagedCareEye.com, will educate managed care and payer professionals regarding best practices in enhancing retinal disease care equity and access.

Learning Objectives

• Identify current disparities in the care of retinal diseases.
• Outline the importance of anti-VEGF therapies with extended duration of effect for patients impacted by SDOH.
• Describe means by which to address the impact of SDOH via utilization management programs.

A Pre-Approval Information Exchange (PIE) Webinar, sponsored by Syndax Pharmaceuticals.

Pre-Approval Information Exchange (PIE) presentation for investigational revumenib, including a clinical overview, burden of disease, and disease background for pediatric and adult patients harboring KMT2A-rearranged relapsed or refractory acute leukemia.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

The AMCP Format for Formulary Submissions (the Format) defines the best practice for pharmaceutical manufacturer dossiers. In April 2024, AMCP released Format version 5.0, the first update to the Format since 2020. In this educational session, two individuals who contributed to the update will provide details of the new and improved Format v5.0.

An AMCP Webinar, hosted by FormularyDecisions^®.

Please join us for an interactive, engaging, and informative discussion to discover the keys to thriving in the dynamic biosimilars landscape. In this interactive session, you will gain practical insights on navigating regulatory challenges, seizing opportunities for collaboration, and communicating effectively with stakeholders.

Stay ahead of the curve with up-to-date industry trends and expert strategies tailored to driving success in the U.S. biosimilars market. Register today to secure your spot!